Neumora Therapeutics 주식 가격. NMRA - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

가격

1.92

매수가

1.90

매도가

1.93

거래량

1,720,855

1.90 일간 변동폭 2.01

1.83 52주 범위 21.00

market_cap

310.197M

전일 종가

1.92

개장가

1.93

최근 거래 시간

454

1.92

(formt)

마지막 거래 시간

재정 규모

US$ 3,386,181

VWAP

1.9677

평균 볼륨(3m)

3,112,537

발행 주식

161,561,064

배당수익률

주가수익률

-1.31

주당순이익(EPS)

-1.46

매출

순이익

-235.93M

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, ... Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; NMRA-266 for the treatment of schizophrenia and other neuropsychiatric disorders; NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. 더 보기

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.neumoratx.com.

본부

New Castle, Delaware, USA

설립됨

Neumora Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker NMRA. The last closing price for Neumora Therapeutics was US$1.92. Over the last year, Neumora Therapeutics shares have traded in a share price range of US$ 1.83 to US$ 21.00.

Neumora Therapeutics currently has 161,561,064 shares in issue. The market capitalisation of Neumora Therapeutics is US$310.20 million. Neumora Therapeutics has a price to earnings ratio (PE ratio) of -1.31.

Form 8-K - Current report

Neumora Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - NMRA

The DJS Law Group announces that it is investigating claims on behalf of investors of Neumora Therapeutics, Inc. (“Neumora” or “the Company”) (NASDAQ: NMRA) for violations of the securities laws...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-0.26	-11.9266055046	2.18	2.18	1.8648	2648338	2.00822614	CS
4	-0.31	-13.9013452915	2.23	2.86	1.8648	5352144	2.2440694	CS
12	-11.13	-85.2873563218	13.05	14.09	1.83	3112537	3.91290792	CS
26	-11.02	-85.1622874807	12.94	17.1874	1.83	1870483	6.44254861	CS
52	-14.28	-88.1481481481	16.2	21	1.83	1239967	7.77330663	CS
156	-14.58	-88.3636363636	16.5	21	1.83	991472	8.25684274	CS
260	-14.58	-88.3636363636	16.5	21	1.83	991472	8.25684274	CS

NMRA - Frequently Asked Questions (FAQ)

What is the current Neumora Therapeutics share price?

The current share price of Neumora Therapeutics is US$ 1.92

How many Neumora Therapeutics shares are in issue?

Neumora Therapeutics has 161,561,064 shares in issue

What is the market cap of Neumora Therapeutics?

The market capitalisation of Neumora Therapeutics is USD 310.2M

What is the 1 year trading range for Neumora Therapeutics share price?

Neumora Therapeutics has traded in the range of US$ 1.83 to US$ 21.00 during the past year

What is the PE ratio of Neumora Therapeutics?

The price to earnings ratio of Neumora Therapeutics is -1.31

What is the reporting currency for Neumora Therapeutics?

Neumora Therapeutics reports financial results in USD

What is the latest annual profit for Neumora Therapeutics?

The latest annual profit of Neumora Therapeutics is USD -235.93M

What is the registered address of Neumora Therapeutics?

The registered address for Neumora Therapeutics is 1209 ORANGE STREET, WILMINGTON 19801, NEW CASTLE, DELAWARE

What is the Neumora Therapeutics website address?

The website address for Neumora Therapeutics is www.neumoratx.com.

Which industry sector does Neumora Therapeutics operate in?

Neumora Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	731.1M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.87M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.57M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.54M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	338.75M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.29M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	234.8M